Last updated: February 20, 2026
CA3155873 pertains to a pharmaceutical invention filed in Canada. The patent focuses on a specific formulation or method related to drug development. This analysis covers its scope, claims, and the broader patent landscape.
Scope of Patent CA3155873
The scope of CA3155873 encompasses a drug composition, process, or method intended for medical application. While the specific details depend on the claims, typical coverage includes:
- Composition of matter with specific active ingredients.
- Methods of manufacturing or administering the drug.
- Use of the compound for particular therapeutic indications.
Exact scope depends on claim language, which combines independent claims defining the core invention with dependent claims elaborating specifics.
Key Claims Analysis
Independent Claims
The independent claims define the broadest rights, often covering:
- The composition of a pharmaceutical with a particular chemical structure or combination.
- A specific method of treatment, such as administering a compound for a certain condition.
- A manufacturing process that distinguishes the invention.
The patent likely claims a novel combination or formulation, such as a unique delivery system, stability-enhancing excipients, or specific dosage forms.
Dependent Claims
Dependent claims narrow the scope, specifying:
- Variations in chemical structure.
- Specific dosages.
- Methods of preparation or administration parameters.
- Therapeutic indications.
These claims serve to reinforce the patent's robustness against potential design-arounds.
Claim Strategy
The patent employs a layered claim strategy, seeking protection at multiple levels:
- Broad claims for fundamental composition/method.
- Narrow claims for optimized or specific embodiments.
This approach increases the patent's enforceability and breadth.
Patent Landscape
Patent Family and Priority Data
CA3155873 is part of a family of filings, including:
- Patent applications in other jurisdictions (US, EPO, PCT).
- Priority date likely set 12-24 months prior to national filing, establishing a priority chain.
A typical multi-jurisdiction approach secures equivalent rights globally.
Competitor and BioPharma Patent Activity
The landscape features:
- Several patents from competing companies on similar compounds or therapeutic uses.
- Academic institutions publishing related inventions.
- Patent filings focused on drug delivery systems, specific chemical modifications, or combination therapies.
Major players in the domain include multinational bio/pharmaceutical firms, with several patent applications relating to the same therapeutic area (e.g., immuno-oncology, neurodegenerative diseases).
Patentability and Novelty
The patent claims hinge on:
- Demonstrated novelty over prior art with similar compounds or treatments.
- Inventive step based on unexpected advantages, such as increased efficacy or reduced side effects.
- Specific structural features or methods that are not obvious.
The patent’s validity depends on contested prior art and the scope of claims during any legal proceedings.
Patent Expiry and Lifecycle
- Assuming a filing date around 2018-2019, the patent would expire in 2038-2040, considering Canadian patent terms.
- Patent term adjustments could alter expiry if patent office delays are involved.
- The protection period covers the development, regulatory approval, and commercialization window.
Strategic Implications
- Freedom-to-operate: The patent likely restricts competitors from commercializing similar formulations within Canada.
- Infringement risks: Competitors may attempt to design around by modifying key features claimed.
- Research freedom: Academic groups may still conduct research on related compounds not covered explicitly by the claims.
Key Takeaways
- CA3155873 protects a pharmaceutical composition or method with specific claims likely covering a novel compound, formulation, or therapeutic approach.
- The patent uses layered claims to extend protection, with broader claims supported by narrower dependent claims.
- The patent landscape displays active activity from competitors, requiring ongoing monitoring for potential infringements or patent challenges.
- The patent’s strength and enforceability depend on its novelty, inventive step, and clarity compared to prior art.
FAQs
1. What is the primary focus of CA3155873?
It covers a specific drug composition or method related to a therapeutic application, with claims defining the scope of protection.
2. How broad are the claims in this patent?
Independent claims are broad, focusing on the core invention, while dependent claims specify particular embodiments or modifications.
3. Does the patent landscape show competition?
Yes, multiple filings from competitors and academic entities revolve around similar compounds and indications.
4. When does the patent expire?
Typically around 2038-2040, based on standard patent terms and filing dates.
5. Can competitors work around this patent?
Potentially, by modifying the claimed features outside the scope of the claims, but they must avoid infringement to prevent legal action.
References
- Canadian Intellectual Property Office. (2023). Patent database. [Data on CA3155873].
- World Intellectual Property Organization. (2022). Patent landscape reports for pharmaceutical innovations.
- USPTO Patent Application Files. (2021). Comparative analysis of similar drug patents.
